1887
banner image
No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
oa
Stereotactic body radiation therapy: The report of AAPM Task Group 101
Rent:
Rent this article for
Access full text Article
/content/aapm/journal/medphys/37/8/10.1118/1.3438081
1.
1.D. W. Andrews, C. B. Scott, P. W. Sperduto, A. E. Flanders, L. E. Gaspar, M. C. Schell, M. Werner-Wasik, W. Demas, J. Ryu, J. P. Bahary, L. Souhami, M. Rotman, M. P. Mehta, and W. J. Curran, Jr., “Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial,” Lancet 363, 16651672 (2004).
http://dx.doi.org/10.1016/S0140-6736(04)16250-8
2.
2.J. C. Flickinger, D. Kondziolka, A. Niranjan, and L. D. Lunsford, “Results of acoustic neuroma radiosurgery: An analysis of 5 years’ experience using current methods,” J. Neurosurg. 94, 16 (2001).
http://dx.doi.org/10.3171/jns.2001.94.1.0001
3.
3.J. C. Flickinger et al., “An analysis of the clinical radiobiology of arteriovenous malformation obliteration by radiosurgery,” Int. J. Radiat. Oncol., Biol., Phys. 48, 255 (2000).
http://dx.doi.org/10.1016/S0360-3016(00)80308-9
4.
4.M. Izawa, M. Hayashi, K. Nakaya, H. Satoh, T. Ochiai, T. Hori, and K. Takakura, “Gamma knife radiosurgery for pituitary adenomas,” J. Neurosurg. 93, 1922 (2000).
http://dx.doi.org/10.3171/jns.2000.93.1.0019
5.
5.S. L. Stafford, B. E. Pollock, R. L. Foote, M. J. Link, D. A. Gorman, P. J. Schomberg, and J. A. Leavitt, “Meningioma radiosurgery: Tumor control, outcomes, and complications among 190 consecutive patients,” Neurosurgery 49, 10291038 (2001).
http://dx.doi.org/10.1097/00006123-200111000-00001
6.
6.B. E. Pollock, L. K. Phuong, D. A. Gorman, R. L. Foote, and S. L. Stafford, “Stereotactic radiosurgery for idiopathic trigeminal neuralgia,” J. Neurosurg. 97, 347353 (2002).
http://dx.doi.org/10.3171/jns.2002.97.2.0347
7.
7.R. F. Young, A. Shumway-Cook, S. S. Vermeulen, P. Grimm, J. Blasko, A. Posewitz, W. A. Burkhart, and R. C. Goiney, “Gamma knife radiosurgery as a lesioning technique in movement disorder surgery,” J. Neurosurg. 89, 183193 (1998).
http://dx.doi.org/10.3171/jns.1998.89.2.0183
8.
8.R. D. Timmerman, “An overview of hypofractionation and introduction to this issue of seminars in radiation oncology,” Semin. Radiat. Oncol. 18, 215222 (2008).
http://dx.doi.org/10.1016/j.semradonc.2008.04.001
9.
9.I. S. Grills, V. S. Mangona, R. Welsh, G. Chmielewski, E. McInerney, S. Martin, J. Wloch, H. Ye, and L. L. Kestin, “Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer,” J. Clin. Oncol. 28, 928935 (2010).
http://dx.doi.org/10.1200/JCO.2009.25.0928
10.
10.R. D. Timmerman, C. S. Bizekis, H. I. Pass, Y. Fong, D. E. Dupuy, L. A. Dawson, and D. Lu, “Local surgical, ablative, and radiation treatment of metastases,” Ca-Cancer J. Clin. 59, 145170 (2009).
http://dx.doi.org/10.3322/caac.20013
11.
11.Y. Fong, A. M. Cohen, J. G. Fortner, W. E. Enker, A. D. Turnbull, D. G. Coit, A. M. Marrero, M. Prasad, L. H. Blumgart, and M. F. Brennan, “Liver resection for colorectal metastases,” J. Clin. Oncol. 15, 938946 (1997).
12.
12.R. A. Patchell, P. A. Tibbs, J. W. Walsh, R. J. Dempsey, Y. Maruyama, R. J. Kryscio, W. R. Markesbery, J. S. Macdonald, and B. Young, “A randomized trial of surgery in the treatment of single metastases to the brain,” N. Engl. J. Med. 322, 494500 (1990).
13.
13.K. E. Rusthoven, S. F. Hammerman, B. D. Kavanagh, M. J. Birtwhistle, M. Stares, and D. R. Camidge, “Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis,” Acta Oncol. 48, 578583 (2009).
http://dx.doi.org/10.1080/02841860802662722
14.
14.S. Hellman and R. R. Weichselbaum, “Oligometastases,” J. Clin. Oncol. 13, 810 (1995).
15.
15.S. Hellman and R. R. Weichselbaum, “Importance of local control in an era of systemic therapy,” Nat. Reviews Clin. Oncol. 2, 6061 (2005).
http://dx.doi.org/10.1038/ncponc0075
16.
16.M. T. Milano, A. W. Katz, A. G. Muhs, A. Philip, D. J. Buchholz, M. C. Schell, and P. Okunieff, “A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions,” Cancer 112, 650658 (2008).
http://dx.doi.org/10.1002/cncr.23209
17.
17.U. Pastorino, M. Buyse, G. Friedel, R. J. Ginsberg, P. Girard, P. Goldstraw, M. Johnston, P. McCormack, H. Pass, and J. B. Putnam, Jr., “Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases,” J. Thorac. Cardiovasc. Surg. 113, 3749 (1997).
http://dx.doi.org/10.1016/S0022-5223(97)70397-0
18.
18.P. J. Wersäll, H. Blomgren, I. Lax, K. M. Kalkner, C. Linder, G. Lundell, B. Nilsson, S. Nilsson, I. Naslund, P. Pisa, and C. Svedman, “Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma,” Radiother. Oncol. 77, 8895 (2005).
http://dx.doi.org/10.1016/j.radonc.2005.03.022
19.
19.J. K. Salama, S. J. Chmura, N. Mehta, K. M. Yenice, W. M. Stadler, E. E. Vokes, D. J. Haraf, S. Hellman, and R. R. Weichselbaum, “An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease,” Clin. Cancer Res. 14, 52555259 (2008).
http://dx.doi.org/10.1158/1078-0432.CCR-08-0358
20.
20.J. C. Yang, J. Abad, and R. Sherry, “Treatment of oligometastases after successful immunotherapy,” Semin. Radiat. Oncol. 16, 131135 (2006).
http://dx.doi.org/10.1016/j.semradonc.2005.12.008
21.
21.R. Simon and L. Norton, “The Norton-Simon hypothesis: Designing more effective and less toxic chemotherapeutic regimens,” Nat. Reviews Clin. Oncol. 3, 406407 (2006).
http://dx.doi.org/10.1038/ncponc0560
22.
22.J. E. Chang, D. Khuntia, H. I. Robins, and M. P. Mehta, “Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme,” Clin Adv Hematol & Oncol 5, 894902 (2007).
23.
23.C. Nieder, M. Adam, M. Molls, and A. L. Grosu, “Therapeutic options for recurrent high-grade glioma in adult patients: Recent advances,” Crit. Rev. Oncol. Hematol. 60, 181193 (2006).
http://dx.doi.org/10.1016/j.critrevonc.2006.06.007
24.
24.H. Joensuu, “Novel cancer therapies: More efficacy, less toxicity and improved organ preservation,” Ann. Med. 32, 3133 (2000).
http://dx.doi.org/10.3109/07853890008995907
25.
25.H. Joensuu and M. Tenhunen, “Physical and biological targeting of radiotherapy,” Acta Oncol. 38, 7583 (1999).
http://dx.doi.org/10.1080/028418699432806
26.
26.H. Blomgren, I. Lax, I. Naslund, and R. Svanstrom, “Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients,” Acta Oncol. 34, 861870 (1995).
http://dx.doi.org/10.3109/02841869509127197
27.
27.K. K. Herfarth, J. Debus, F. Lohr, M. L. Bahner, P. Fritz, A. Hoss, W. Schlegel, and M. F. Wannenmacher, “Extracranial stereotactic radiation therapy: Set-up accuracy of patients treated for liver metastases,” Int. J. Radiat. Oncol., Biol., Phys. 46, 329335 (2000).
http://dx.doi.org/10.1016/S0360-3016(99)00413-7
28.
28.K. K. Herfarth, J. Debus, F. Lohr, M. L. Bahner, B. Rhein, P. Fritz, A. Hoss, W. Schlegel, and M. F. Wannenmacher, “Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial,” J. Clin. Oncol. 19, 164170 (2001).
29.
29.K. K. Herfarth, J. Debus, F. Lohr, M. L. Bahner, and M. Wannenmacher, “Stereotactic irradiation of liver metastases,” Radiologe 41, 6468 (2001).
http://dx.doi.org/10.1007/s001170050928
30.
30.K. K. Herfarth, J. Debus, and M. Wannenmacher, “Stereotactic radiation therapy of liver metastases: Update of the initial phase-I/II trial,” Front. Radiat. Ther. Oncol. 38, 100105 (2004).
http://dx.doi.org/10.1159/000078271
31.
31.J. Wulf, U. Hadinger, U. Oppitz, W. Thiele, R. Ness-Dourdoumas, and M. Flentje, “Stereotactic radiotherapy of targets in the lung and liver,” Strahlenther. Onkol. 177, 645655 (2001).
http://dx.doi.org/10.1007/PL00002379
32.
32.R. Timmerman, L. Papiez, R. McGarry, L. Likes, C. DesRosiers, S. Frost, and M. Williams, “Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer,” Chest 124, 19461955 (2003).
http://dx.doi.org/10.1378/chest.124.5.1946
33.
33.R. I. Whyte, R. Crownover, M. J. Murphy, D. P. Martin, T. W. Rice, M. M. DeCamp, Jr., R. Rodebaugh, M. S. Weinhous, and Q. T. Le, “Stereotactic radiosurgery for lung tumors: Preliminary report of a phase I trial,” Ann. Thorac. Surg. 75, 10971101 (2003).
http://dx.doi.org/10.1016/S0003-4975(02)04681-7
34.
34.S. Fukumoto, H. Shirato, S. Shimzu, S. Ogura, R. Onimaru, K. Kitamura, K. Yamazaki, K. Miyasaka, M. Nishimura, and H. Dosaka-Akita, “Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas,” Cancer 95, 15461553 (2002).
http://dx.doi.org/10.1002/cncr.10853
35.
35.R. Hara, J. Itami, T. Kondo, T. Aruga, Y. Abe, M. Ito, M. Fuse, D. Shinohara, T. Nagaoka, and T. Kobiki, “Stereotactic single high dose irradiation of lung tumors under respiratory gating,” Radiother. Oncol. 63, 159163 (2002).
http://dx.doi.org/10.1016/S0167-8140(02)00063-4
36.
36.S. W. Lee, E. K. Choi, H. J. Park, S. D. Ahn, J. H. Kim, K. J. Kim, S. M. Yoon, Y. S. Kim, and B. Y. Yi, “Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung,” Lung Cancer 40, 309315 (2003).
37.
37.Y. Nagata, Y. Negoro, T. Aoki, T. Mizowaki, K. Takayama, M. Kokubo, N. Araki, M. Mitsumori, K. Sasai, Y. Shibamoto, S. Koga, S. Yano, and M. Hiraoka, “Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame,” Int. J. Radiat. Oncol., Biol., Phys. 52, 10411046 (2002).
http://dx.doi.org/10.1016/S0360-3016(01)02731-6
38.
38.H. Onishi et al., “Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study,” Cancer 101, 16231631 (2004).
http://dx.doi.org/10.1002/cncr.20539
39.
39.M. Uematsu et al., “Computed tomography (CT)-guided stereotactic radiation therapy (SRT) for stage I non-small cell lung cancer (NSCLC): 8-year results of 50 initial patients,” Int. J. Radiat. Oncol., Biol., Phys. 57, S281 (2003).
http://dx.doi.org/10.1016/S0360-3016(03)01132-5
40.
40.D. L. Benzil, M. Saboori, A. Y. Mogilner, R. Rocchio, and C. R. Moorthy, “Safety and efficacy of stereotactic radiosurgery for tumors of the spine,” J. Neurosurg. 101, 413418 (2004).
41.
41.M. H. Bilsky, Y. Yamada, K. M. Yenice, M. Lovelock, M. Hunt, P. H. Gutin, and S. A. Leibel, “Intensity-modulated stereotactic radiotherapy of paraspinal tumors: A preliminary report,” Neurosurgery 54(3), 823830 (2004).
http://dx.doi.org/10.1227/01.NEU.0000114263.01917.1E
42.
42.E. L. Chang, A. S. Shiu, M. F. Lii, L. D. Rhines, E. Mendel, A. Mahajan, J. S. Weinberg, L. A. Mathews, B. W. Brown, M. H. Maor, and J. D. Cox, “Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases,” Int. J. Radiat. Oncol., Biol., Phys. 59, 12881294 (2004).
http://dx.doi.org/10.1016/j.ijrobp.2004.01.002
43.
43.S. Ryu, F. F. Yin, J. Rock, J. Zhu, A. Chu, E. Kagan, L. Rogers, M. Ajlouni, M. Rosenblum, and J. H. Kim, “Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis,” Cancer 97, 20132018 (2003).
http://dx.doi.org/10.1002/cncr.11296
44.
44.S. Ryu, J. Rock, M. Rosenblum, and J. H. Kim, “Patterns of failure after single-dose radiosurgery for spinal metastasis,” J. Neurosurg. 101, 402405 (2004).
http://dx.doi.org/10.3171/jns.2004.101.3.0402
45.
45.J. Bradley, M. V. Graham, K. Winter, J. A. Purdy, R. Komaki, W. H. Roa, J. K. Ryu, W. Bosch, and B. Emami, “Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma,” Int. J. Radiat. Oncol., Biol., Phys. 61, 318328 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2004.06.260
46.
46.P. C. Gerszten, S. A. Burton, and C. Ozhasoglu, “CyberKnife radiosurgery for spinal neoplasms,” Prog. Neurol. Surg. 20, 340358 (2007).
http://dx.doi.org/10.1159/000100177
47.
47.P. C. Gerszten, S. A. Burton, C. Ozhasoglu, and W. C. Welch, “Radiosurgery for spinal metastases: Clinical experience in 500 cases from a single institution,” Spine 32, 193199 (2007).
http://dx.doi.org/10.1097/01.brs.0000251863.76595.a2
48.
48.L. A. Dawson, D. Normolle, J. M. Balter, C. J. McGinn, T. S. Lawrence, and R. K. Ten Haken, “Analysis of radiation-induced liver disease using the Lyman NTCP model,” Int. J. Radiat. Oncol., Biol., Phys. 53, 810821 (2002).
http://dx.doi.org/10.1016/S0360-3016(02)02846-8
49.
49.R. C. McGarry, L. Papiez, M. Williams, T. Whitford, and R. D. Timmerman, “Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: Phase I study,” Int. J. Radiat. Oncol., Biol., Phys. 63, 10101015 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2005.03.073
50.
50.T. E. Schefter, B. D. Kavanagh, R. D. Timmerman, H. R. Cardenes, A. Baron, and L. E. Gaspar, “A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases,” Int. J. Radiat. Oncol., Biol., Phys. 62, 13711378 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2005.01.002
51.
51.G. R. Borst, M. Ishikawa, J. Nijkamp, M. Hauptmann, H. Shirato, R. Onimaru, M. M. van den Heuvel, J. Belderbos, J. V. Lebesque, and J. J. Sonke, “Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy,” Radiother. Oncol. 91, 307313 (2009).
http://dx.doi.org/10.1016/j.radonc.2009.02.003
52.
52.M. Hoyer, H. Roed, L. Sengelov, A. Traberg, L. Ohlhuis, J. Pedersen, H. Nellemann, A. Kiil Berthelsen, F. Eberholst, S. A. Engelholm, and H. von der Maase, “Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma,” Radiother. Oncol. 76, 4853 (2005).
http://dx.doi.org/10.1016/j.radonc.2004.12.022
53.
53.M. Hoyer, H. Roed, A. Traberg Hansen, L. Ohlhuis, J. Petersen, H. Nellemann, A. Kiil Berthelsen, C. Grau, S. Aage Engelholm, and H. Von der Maase, “Phase II study on stereotactic body radiotherapy of colorectal metastases,” Acta Oncol. 45, 823830 (2006).
http://dx.doi.org/10.1080/02841860600904854
54.
54.A. C. Koong, E. Christofferson, Q. T. Le, K. A. Goodman, A. Ho, T. Kuo, J. M. Ford, G. A. Fisher, R. Greco, J. Norton, and G. P. Yang, “Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer,” Int. J. Radiat. Oncol., Biol., Phys. 63, 320323 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2005.07.002
55.
55.H. U. Kauczor, C. P. Heussel, and M. Thelen, “Radiodiagnosis of the lung,” Radiologe 40, 870877 (2000).
http://dx.doi.org/10.1007/s001170050846
56.
56.R. Komaki, J. B. Putnam, Jr., G. Walsh, J. S. Lee, and J. D. Cox, “The management of superior sulcus tumors,” Semin Surg. Oncol. 18, 152164 (2000).
http://dx.doi.org/10.1002/(SICI)1098-2388(200003)18:2<152::AID-SSU9>3.0.CO;2-H
57.
57.I. R. Kamel and E. K. Fishman, “Recent advances in CT imaging of liver metastases,” Cancer J. 10, 104120 (2004).
http://dx.doi.org/10.1097/00130404-200403000-00006
58.
58.I. R. Kamel, E. Liapi, and E. K. Fishman, “Multidetector CT of hepatocellular carcinoma,” Best Pract. Res. Clin. Gastroenterol. 19, 6389 (2005).
http://dx.doi.org/10.1016/j.bpg.2004.10.005
59.
59.M. Debois, R. Oyen, F. Maes, G. Verswijvel, G. Gatti, H. Bosmans, M. Feron, E. Bellon, G. Kutcher, H. van Poppel, and L. Vanuytsel, “The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer,” Int. J. Radiat. Oncol., Biol., Phys. 45, 857865 (1999).
http://dx.doi.org/10.1016/S0360-3016(99)00288-6
60.
60.C. Rasch, I. Barillot, P. Remeijer, A. Touw, M. van Herk, and J. V. Lebesque, “Definition of the prostate in CT and MRI: A multi-observer study,” Int. J. Radiat. Oncol., Biol., Phys. 43, 5766 (1999).
http://dx.doi.org/10.1016/S0360-3016(98)00351-4
61.
61.S. F. Tanner, D. J. Finnigan, V. S. Khoo, P. Mayles, D. P. Dearnaley, and M. O. Leach, “Radiotherapy planning of the pelvis using distortion corrected MR images: The removal of system distortions,” Phys. Med. Biol. 45, 21172132 (2000).
http://dx.doi.org/10.1088/0031-9155/45/8/305
62.
62.D. J. Husband, K. A. Grant, and C. S. Romaniuk, “MRI in the diagnosis and treatment of suspected malignant spinal cord compression,” Br. J. Radiol. 74, 1523 (2001).
63.
63.T. Mizowaki, N. Araki, Y. Nagata, Y. Negoro, T. Aoki, and M. Hiraoka, “The use of a permanent magnetic resonance imaging system for radiotherapy treatment planning of bone metastases,” Int. J. Radiat. Oncol., Biol., Phys. 49, 605611 (2001).
http://dx.doi.org/10.1016/S0360-3016(00)01472-3
64.
64.W. R. Webb, C. Gatsonis, E. A. Zerhouni, R. T. Heelan, G. M. Glazer, I. R. Francis, and B. J. McNeil, “CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group,” Radiology 178, 705713 (1991).
65.
65.R. Komaki, C. F. Mountain, J. M. Holbert, A. S. Garden, R. Shallenberger, J. D. Cox, M. H. Maor, V. F. Guinee, and B. Samuels, “Superior sulcus tumors: Treatment selection and results for 85 patients without metastasis (Mo) at presentation,” Int. J. Radiat. Oncol., Biol., Phys. 19, 3136 (1990).
http://dx.doi.org/10.1016/0360-3016(90)90130-C
66.
66.P. Günther, J. P. Schenk, R. Wunsch, J. Troger, and K. L. Waag, “Abdominal tumours in children: 3-D visualisation and surgical planning,” Eur. J. Pediatr. Surg. 14, 316321 (2004).
http://dx.doi.org/10.1055/s-2004-821042
67.
67.S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. Silverman, R. E. Coleman, and M. E. Phelps, “A tabulated summary of the FDG PET literature,” J. Nucl. Med. 42, 1S93S (2001).
68.
68.N. C. Gupta, G. M. Graeber, W. J. Tamim, J. S. Rogers, L. Irisari, and H. A. Bishop, “Clinical utility of PET-FDG imaging in differentiation of benign from malignant adrenal masses in lung cancer,” Clin. Lung Cancer 3, 5964 (2001).
http://dx.doi.org/10.3816/CLC.2001.n.019
69.
69.D. Lardinois, W. Weder, T. F. Hany, E. M. Kamel, S. Korom, B. Seifert, G. K. von Schulthess, and H. C. Steinert, “Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography,” N. Engl. J. Med. 348, 25002507 (2003).
http://dx.doi.org/10.1056/NEJMoa022136
70.
70.A. M. Gharib, D. Thomasson, and K. C. Li, “Molecular imaging of hepatocellular carcinoma,” Gastroenterology 127, S153S158 (2004).
http://dx.doi.org/10.1053/j.gastro.2004.09.029
71.
71.W. Y. Lin, S. C. Tsai, and G. U. Hung, “Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma,” Nucl. Med. Commun. 26, 315321 (2005).
http://dx.doi.org/10.1097/00006231-200504000-00003
72.
72.B. A. Fraass and D. L. McShan, in Radiation Therapy Physics, edited by A. R. Smith (Springer-Verlag, Berlin, 1995), pp. 139154.
73.
73.D. G. Disler, D. S. Marr, and D. I. Rosenthal, “Accuracy of volume measurements of computed tomography and magnetic resonance imaging phantoms by three-dimensional reconstruction and preliminary clinical application,” Invest. Radiol. 29, 739745 (1994).
http://dx.doi.org/10.1097/00004424-199408000-00002
74.
74.A. Somigliana, G. Zonca, G. Loi, and A. E. Sichirollo, “How thick should CT/MR slices be to plan conformal radiotherapy? A study on the accuracy of three-dimensional volume reconstruction,” Tumori 82, 470472 (1996).
75.
75.H. T. Winer-Muram, S. G. Jennings, C. A. Meyer, Y. Liang, A. M. Aisen, R. D. Tarver, and R. C. McGarry, “Effect of varying CT section width on volumetric measurement of lung tumors and application of compensatory equations,” Radiology 229, 184194 (2003).
http://dx.doi.org/10.1148/radiol.2291020859
76.
76.Q. S. Chen, M. S. Weinhous, F. C. Deibel, J. P. Ciezki, and R. M. Macklis, “Fluoroscopic study of tumor motion due to breathing: Facilitating precise radiation therapy for lung cancer patients,” Med. Phys. 28, 18501856 (2001).
http://dx.doi.org/10.1118/1.1398037
77.
77.Y. Seppenwoolde, H. Shirato, K. Kitamura, S. Shimizu, M. van Herk, J. V. Lebesque, and K. Miyasaka, “Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 53, 822834 (2002).
http://dx.doi.org/10.1016/S0360-3016(02)02803-1
78.
78.C. W. Stevens, R. F. Munden, K. M. Forster, J. F. Kelly, Z. Liao, G. Starkschall, S. Tucker, and R. Komaki, “Respiratory-driven lung tumor motion is independent of tumor size, tumor location, and pulmonary function,” Int. J. Radiat. Oncol., Biol., Phys. 51, 6268 (2001).
http://dx.doi.org/10.1016/S0360-3016(01)01621-2
79.
79.C. B. Caldwell, K. Mah, M. Skinner, and C. E. Danjoux, “Can PET provide the 3D extent of tumor motion for individualized internal target volumes? A phantom study of the limitations of CT and the promise of PET,” Int. J. Radiat. Oncol., Biol., Phys. 55, 13811393 (2003).
http://dx.doi.org/10.1016/S0360-3016(02)04609-6
80.
80.G. T. Chen, J. H. Kung, and K. P. Beaudette, “Artifacts in computed tomography scanning of moving objects,” Semin. Radiat. Oncol. 14, 1926 (2004).
http://dx.doi.org/10.1053/j.semradonc.2003.10.004
81.
81.F. J. Lagerwaard, J. R. van Sornsen de Koste, M. R. Nijssen-Visser, R. H. Schuchhard-Schipper, S. S. Oei, A. Munne, and S. Senan, “Multiple ‘slow’ CT scans for incorporating lung tumor mobility in radiotherapy planning,” Int. J. Radiat. Oncol., Biol., Phys. 51, 932937 (2001).
http://dx.doi.org/10.1016/S0360-3016(01)01716-3
82.
82.K. Takayama, Y. Nagata, Y. Negoro, T. Mizowaki, T. Sakamoto, M. Sakamoto, T. Aoki, S. Yano, S. Koga, and M. Hiraoka, “Treatment planning of stereotactic radiotherapy for solitary lung tumor,” Int. J. Radiat. Oncol., Biol., Phys. 61, 15651571 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2004.12.066
83.
83.M. Uematsu, A. Shioda, K. Tahara, T. Fukui, F. Yamamoto, G. Tsumatori, Y. Ozeki, T. Aoki, M. Watanabe, and S. Kusano, “Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience,” Cancer 82, 10621070 (1998).
http://dx.doi.org/10.1002/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G
84.
84.G. S. Mageras and E. Yorke, “Deep inspiration breath hold and respiratory gating strategies for reducing organ motion in radiation treatment,” Semin. Radiat. Oncol. 14, 6575 (2004).
http://dx.doi.org/10.1053/j.semradonc.2003.10.009
85.
85.E. A. Barnes, B. R. Murray, D. M. Robinson, L. J. Underwood, J. Hanson, and W. H. Roa, “Dosimetric evaluation of lung tumor immobilization using breath hold at deep inspiration,” Int. J. Radiat. Oncol., Biol., Phys. 50, 10911098 (2001).
http://dx.doi.org/10.1016/S0360-3016(01)01592-9
86.
86.J. Hanley, M. M. Debois, D. Mah, G. S. Mageras, A. Raben, K. Rosenzweig, B. Mychalczak, L. H. Schwartz, P. J. Gloeggler, W. Lutz, C. C. Ling, S. A. Leibel, Z. Fuks, and G. J. Kutcher, “Deep inspiration breath-hold technique for lung tumors: The potential value of target immobilization and reduced lung density in dose escalation,” Int. J. Radiat. Oncol., Biol., Phys. 45, 603611 (1999).
http://dx.doi.org/10.1016/S0360-3016(99)00154-6
87.
87.H. Onishi, K. Kuriyama, T. Komiyama, S. Tanaka, J. Ueki, N. Sano, T. Araki, S. Ikenaga, Y. Tateda, and Y. Aikawa, “CT evaluation of patient deep inspiration self-breath-holding: How precisely can patients reproduce the tumor position in the absence of respiratory monitoring devices?,” Med. Phys. 30, 11831187 (2003).
http://dx.doi.org/10.1118/1.1570372
88.
88.L. Wang, S. Feigenberg, L. Chen, K. Pasklev, and C. C. Ma, “Benefit of three-dimensional image-guided stereotactic localization in the hypofractionated treatment of lung cancer,” Int. J. Radiat. Oncol., Biol., Phys. 66, 738747 (2006).
http://dx.doi.org/10.1016/j.ijrobp.2006.05.032
89.
89.R. C. Frazier, F. A. Vicini, M. B. Sharpe, D. Yan, J. Fayad, K. L. Baglan, L. L. Kestin, V. M. Remouchamps, A. A. Martinez, and J. W. Wong, “Impact of breathing motion on whole breast radiotherapy: A dosimetric analysis using active breathing control,” Int. J. Radiat. Oncol., Biol., Phys. 58, 10411047 (2004).
http://dx.doi.org/10.1016/j.ijrobp.2003.07.005
90.
90.V. M. Remouchamps, N. Letts, F. A. Vicini, M. B. Sharpe, L. L. Kestin, P. Y. Chen, A. A. Martinez, and J. W. Wong, “Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 56, 704715 (2003).
http://dx.doi.org/10.1016/S0360-3016(03)00163-9
91.
91.V. M. Remouchamps, N. Letts, D. Yan, F. A. Vicini, M. Moreau, J. A. Zielinski, J. Liang, L. L. Kestin, A. A. Martinez, and J. W. Wong, “Three-dimensional evaluation of intra- and interfraction immobilization of lung and chest wall using active breathing control: A reproducibility study with breast cancer patients,” Int. J. Radiat. Oncol., Biol., Phys. 57, 968978 (2003).
http://dx.doi.org/10.1016/S0360-3016(03)00710-7
92.
92.V. M. Remouchamps, F. A. Vicini, M. B. Sharpe, L. L. Kestin, A. A. Martinez, and J. W. Wong, “Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation,” Int. J. Radiat. Oncol., Biol., Phys. 55, 392406 (2003).
http://dx.doi.org/10.1016/S0360-3016(02)04143-3
93.
93.J. W. Wong, M. B. Sharpe, and D. A. Jaffray, “The use of active breathing control (ABC) to minimize breathing motion during radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 39, 164 (1997).
http://dx.doi.org/10.1016/S0360-3016(97)80617-7
94.
94.F. F. Yin, J. Zhu, H. Yan, H. Gaun, R. Hammoud, S. Ryu, and J. H. Kim, “Dosimetric characteristics of Novalis shaped beam surgery unit,” Med. Phys. 29, 17291738 (2002).
http://dx.doi.org/10.1118/1.1494830
95.
95.B. J. Slotman, F. J. Lagerwaard, and S. Senan, “4D imaging for target definition in stereotactic radiotherapy for lung cancer,” Acta Oncol. 45, 966972 (2006).
http://dx.doi.org/10.1080/02841860600902817
96.
96.R. W. Underberg, F. J. Lagerwaard, B. J. Slotman, J. P. Cuijpers, and S. Senan, “Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer,” Int. J. Radiat. Oncol., Biol., Phys. 63, 253260 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2005.05.045
97.
97.K. S. Cover, F. J. Lagerwaard, and S. Senan, “Color intensity projections: A rapid approach for evaluating four-dimensional CT scans in treatment planning,” Int. J. Radiat. Oncol., Biol., Phys. 64, 954961 (2006).
http://dx.doi.org/10.1016/j.ijrobp.2005.10.006
98.
98.J. H. Lewis and S. B. Jiang, “A theoretical model for respiratory motion artifacts in free-breathing CT scans,” Phys. Med. Biol. 54, 745755 (2009).
http://dx.doi.org/10.1088/0031-9155/54/3/018
99.
99.M. A. Barish and H. Jara, “Motion artifact control in body MR imaging,” Magn. Reson Imaging Clin. N. Am. 7, 289301 (1999).
100.
100.R. T. Constable, “MR physics of body MR imaging,” Radiol. Clin. North Am. 41, 115 (2003).
http://dx.doi.org/10.1016/S0033-8389(02)00070-2
101.
101.S. Eustace, R. Goldberg, D. Williamson, E. R. Melhem, O. Oladipo, E. K. Yucel, and H. Jara, “MR imaging of soft tissues adjacent to orthopaedic hardware: Techniques to minimize susceptibility artefact,” Clin. Radiol. 52, 589594 (1997).
http://dx.doi.org/10.1016/S0009-9260(97)80250-4
102.
102.A. Guermazi, Y. Miaux, S. Zaim, C. G. Peterfy, D. White, and H. K. Genant, “Metallic artefacts in MR imaging: Effects of main field orientation and strength,” Clin. Radiol. 58, 322328 (2003).
http://dx.doi.org/10.1016/S0009-9260(02)00540-8
103.
103.S. H. Kolind, A. L. MacKay, P. L. Munk, and Q. S. Xiang, “Quantitative evaluation of metal artifact reduction techniques,” J. Magn. Reson Imaging 20, 487495 (2004).
http://dx.doi.org/10.1002/jmri.20144
104.
104.S. A. Nehmeh, Y. E. Erdi, C. C. Ling, K. E. Rosenzweig, O. D. Squire, L. E. Braban, E. Ford, K. Sidhu, G. S. Mageras, S. M. Larson, and J. L. Humm, “Effect of respiratory gating on reducing lung motion artifacts in PET imaging of lung cancer,” Med. Phys. 29, 366371 (2002).
http://dx.doi.org/10.1118/1.1448824
105.
105.S. A. Nehmeh, Y. E. Erdi, T. Pan, A. Pevsner, K. E. Rosenzweig, E. Yorke, G. S. Mageras, H. Schoder, P. Vernon, O. Squire, H. Mostafavi, S. M. Larson, and J. L. Humm, “Four-dimensional (4D) PET/CT imaging of the thorax,” Med. Phys. 31, 31793186 (2004).
http://dx.doi.org/10.1118/1.1809778
106.
106.S. A. Nehmeh, Y. E. Erdi, T. Pan, E. Yorke, G. S. Mageras, K. E. Rosenzweig, H. Schoder, H. Mostafavi, O. Squire, A. Pevsner, S. M. Larson, and J. L. Humm, “Quantitation of respiratory motion during 4D-PET/CT acquisition,” Med. Phys. 31, 13331338 (2004).
http://dx.doi.org/10.1118/1.1739671
107.
107.S. A. Nehmeh, Y. E. Erdi, K. E. Rosenzweig, H. Schoder, S. M. Larson, O. D. Squire, and J. L. Humm, “Reduction of respiratory motion artifacts in PET imaging of lung cancer by respiratory correlated dynamic PET: Methodology and comparison with respiratory gated PET,” J. Nucl. Med. 44, 16441648 (2003).
108.
108.H. Cardenes, R. Timmerman, and L. Papiez, “Extracranial stereotactic radioablation: Review of biological basis, technique and preliminary clinical experience,” Oncologica 25, 193199 (2002).
http://dx.doi.org/10.1159/000064309
109.
109.I. Lax, H. Blomgren, I. Naslund, and R. Svanstrom, “Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects,” Acta Oncol. 33, 677683 (1994).
http://dx.doi.org/10.3109/02841869409121782
110.
110.L. Papiez, “Leaf sweep algorithm for immobile and moving target as an optimal control problem,” Math. Comput. Modell. 37, 735745 (2003).
http://dx.doi.org/10.1016/S0895-7177(03)00081-5
111.
111.R. M. Cardinale, Q. Wu, S. H. Benedict, B. D. Kavanagh, E. Bump, and R. Mohan, “Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 45, 515520 (1999).
http://dx.doi.org/10.1016/S0360-3016(99)00203-5
112.
112.ICRU, “Prescribing, recording, and reporting photon beam therapy,” ICRU Report No. 50, 1993.
113.
113.ICRU, “Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report No. 50),” ICRU Report No. 62, 1999.
114.
114.I. S. Grills, D. L. Fitch, N. S. Goldstein, D. Yan, G. W. Chmielewski, R. J. Welsh, and L. L. Kestin, “Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: Defining clinical target volume for radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 69, 334341 (2007).
http://dx.doi.org/10.1016/j.ijrobp.2007.03.023
115.
115.L. Papiez, V. Moskvin, and R. D. Timmerman, in Stereotactic Body Radiation Therapy, edited by B. D. Kavanagh and R. D. Timmerman (Lippincott Williams and Wilkis, Philadelphia, 2004), p. 160.
116.
116.U. Hadinger, W. Thiele, and J. Wulf, “Extracranial stereotactic radiotherapy: Evaluation of PTV coverage and dose conformity,” Z. Med. Phys. 12, 221229 (2002).
117.
117.H. Hof, K. K. Herfarth, M. Munter, A. Hoess, J. Motsch, M. Wannenmacher, and J. J. Debus, “Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC),” Int. J. Radiat. Oncol., Biol., Phys. 56, 335341 (2003).
http://dx.doi.org/10.1016/S0360-3016(02)04504-2
118.
118.J. Wulf, U. Haedinger, U. Oppitz, W. Thiele, G. Mueller, and M. Flentje, “Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients,” Int. J. Radiat. Oncol., Biol., Phys. 60, 186196 (2004).
http://dx.doi.org/10.1016/j.ijrobp.2004.07.161
119.
119.J. J. Sonke, M. Rossi, J. Wolthaus, M. van Herk, E. Damen, and J. Belderbos, “Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance,” Int. J. Radiat. Oncol., Biol., Phys. 74, 567574 (2009).
http://dx.doi.org/10.1016/j.ijrobp.2008.08.004
120.
120.J. F. Fowler, W. A. Tome, J. D. Fenwick, and M. P. Mehta, “A challenge to traditional radiation oncology,” Int. J. Radiat. Oncol., Biol., Phys. 60, 12411256 (2004).
http://dx.doi.org/10.1016/j.ijrobp.2004.07.140
121.
121.Z. Lin, J. Mechalakos, S. Nehmeh, H. Schoder, N. Lee, J. Humm, and C. C. Ling, “The influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography,” Int. J. Radiat. Oncol., Biol., Phys. 70, 12191228 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.09.050
122.
122.R. McCammon, T. E. Schefter, L. E. Gaspar, R. Zaemisch, D. Gravdahl, and B. Kavanagh, “Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 73, 112118 (2009).
http://dx.doi.org/10.1016/j.ijrobp.2008.03.062
123.
123.L. Papiez, R. Timmerman, C. DesRosiers, and M. Randall, “Extracranial stereotactic radioablation: Physical principles,” Acta Oncol. 42, 882894 (2003).
http://dx.doi.org/10.1080/02841860310013490
124.
124.Q. J. Wu, Z. Wang, J. P. Kirkpatrick, Z. Chang, J. J. Meyer, M. Lu, C. Huntzinger, and F. F. Yin, “Impact of collimator leaf width and treatment technique on stereotactic radiosurgery and radiotherapy plans for intra- and extracranial lesions,” Radiat. Oncol. 4 (2009).
http://dx.doi.org/10.1186/1748-717X-4-3
125.
125.M. Ding, F. Newman, C. Chen, K. Stuhr, and L. E. Gaspar, “Dosimetric comparison between 3DCRT and IMRT using different multileaf collimators in the treatment of brain tumors,” Med. Dosim. 34, 18 (2009).
http://dx.doi.org/10.1016/j.meddos.2007.04.001
126.
126.J. Y. Jin, F. F. Yin, S. Ryu, M. Ajlouni, and J. H. Kim, “Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery,” Med. Phys. 32, 405411 (2005).
http://dx.doi.org/10.1118/1.1842911
127.
127.J. E. Monk, J. R. Perks, D. Doughty, and P. N. Plowman, “Comparison of a micro-multileaf collimator with a 5-mm-leaf-width collimator for intracranial stereotactic radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 57, 14431449 (2003).
http://dx.doi.org/10.1016/S0360-3016(03)01579-7
128.
128.L. Papiez, M. Langer, and X. Lu, “On the isotropic distribution of beam directions,” Math. Models Meth. Appl. Sci. 10, 9911000 (2000).
129.
129.H. Blomgren et al., “Radiosurgery for tumors in the body: Clinical experience using a new method,” J Radiosurg 1, 6374 (1998).
http://dx.doi.org/10.1023/B:JORA.0000010880.40483.c4
130.
130.M. M. Matuszak, D. Yan, I. Grills and A. Martinez, “Clinical applications of volumetric modulated arc therapy,” Int. J. Radiat. Oncol., Biol., Phys. 77, 608616.
131.
131.K. M. Yenice, D. M. Lovelock, M. A. Hunt, W. R. Lutz, N. Fournier-Bidoz, C. H. Hua, J. Yamada, M. Bilsky, H. Lee, K. Pfaff, S. V. Spirou, and H. I. Amols, “CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization,” Int. J. Radiat. Oncol., Biol., Phys. 55, 583593 (2003).
http://dx.doi.org/10.1016/S0360-3016(02)03942-1
132.
132.K. Yenice, “Advanced treatment techniques II,” in A Practical Guide to Intensity-Modulated Radiation Therapy (Medical Physics Publishing, Madison, 1993), p. 450.
133.
133.J. F. Dempsey, H. E. Romeijn, J. G. Li, D. A. Low, and J. R. Palta, “A Fourier analysis of the dose grid resolution required for accurate IMRT fluence map optimization,” Med. Phys. 32, 380388 (2005).
http://dx.doi.org/10.1118/1.1843354
134.
134.J. L. Bedford, P. J. Childs, V. Nordmark Hansen, M. A. Mosleh-Shirazi, F. Verhaegen, and A. P. Warrington, “Commissioning and quality assurance of the Pinnacle(3) radiotherapy treatment planning system for external beam photons,” Br. J. Radiol. 76, 163176 (2003).
http://dx.doi.org/10.1259/bjr/42085182
135.
135.H. Chung, H. Jin, J. Palta, T. S. Suh, and S. Kim, “Dose variations with varying calculation grid size in head and neck IMRT,” Phys. Med. Biol. 51, 48414856 (2006).
http://dx.doi.org/10.1088/0031-9155/51/19/008
136.
136.B. G. Douglas and J. F. Fowler, “The effect of multiple small doses of x rays on skin reactions in the mouse and a basic interpretation,” Radiat. Res. 66, 401426 (1976).
http://dx.doi.org/10.2307/3574407
137.
137.J. V. Lebesque and R. B. Keus, “The simultaneous boost technique: The concept of relative normalized total dose,” Radiother. Oncol. 22, 4555 (1991).
http://dx.doi.org/10.1016/0167-8140(91)90068-R
138.
138.H. R. Withers, H. D. Thames, Jr., and L. J. Peters, “A new isoeffect curve for change in dose per fraction,” Radiother. Oncol. 1, 187191 (1983).
http://dx.doi.org/10.1016/S0167-8140(83)80021-8
139.
139.A. Niemierko, “Reporting and analyzing dose distributions: A concept of equivalent uniform dose,” Med. Phys. 24, 103110 (1997).
http://dx.doi.org/10.1118/1.598063
140.
140.B. D. Kavanagh, R. D. Timmerman, S. H. Benedict, Q. Wu, T. E. Schefter, K. Stuhr, S. McCourt, F. Newman, R. M. Cardinale, and L. F. Gaspar, “How should we describe the radioblologic effect of extracranial stereotactic radiosurgery: Equivalent uniform dose or tumor control probability?,” Med. Phys. 30, 321324 (2003).
http://dx.doi.org/10.1118/1.1543571
141.
141.H. Suit, S. Skates, A. Taghian, P. Okunieff, and J. T. Efird, “Clinical implications of heterogeneity of tumor response to radiation therapy,” Radiother. Oncol. 25, 251260 (1992).
http://dx.doi.org/10.1016/0167-8140(92)90244-O
142.
142.W. A. Tome, J. D. Fenwick, and M. P. Mehta, “How can tumor effects and normal tissue effects be balanced in stereotactic body radiotherapy?,” Radiosurgery 6, 8697 (2005).
143.
143.M. K. Martel, R. K. Ten Haken, M. B. Hazuka, M. L. Kessler, M. Strawderman, A. T. Turrisi, T. S. Lawrence, B. A. Fraass, and A. S. Lichter, “Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients,” Lung Cancer 24, 3137 (1999).
http://dx.doi.org/10.1016/S0169-5002(99)00019-7
144.
144.M. Guckenberger, J. Wulf, G. Mueller, T. Krieger, K. Baier, M. Gabor, A. Richter, J. Wilbert, and M. Flentje, “Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: Relevance of 4D dose calculation,” Int. J. Radiat. Oncol., Biol., Phys. 74, 4754 (2009).
http://dx.doi.org/10.1016/j.ijrobp.2008.06.1939
145.
145.R. Onimaru, M. Fujino, K. Yamazaki, Y. Onodera, H. Taguchi, N. Katoh, F. Hommura, S. Oizumi, M. Nishimura, and H. Shirato, “Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 70, 374381 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.06.043
146.
146.H. Onishi et al., “Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study,” J. Thorac. Oncol. 2, S94S100 (2007).
http://dx.doi.org/10.1097/JTO.0b013e318074de34
147.
147.J. P. Kirkpatrick, J. J. Meyer, and L. B. Marks, “The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery,” Semin. Radiat. Oncol. 18, 240243 (2008).
http://dx.doi.org/10.1016/j.semradonc.2008.04.005
148.
148.D. Lea and D. Catcheside, “The mechanism of induction by radiation of chromosome aberrations in tradescentia,” Genetics 44, 216245 (1942).
http://dx.doi.org/10.1007/BF02982830
149.
149.C. Park, L. Papiez, S. Zhang, M. Story, and R. D. Timmerman, “Universal survival curve and single fraction equivalent dose: Useful tools in understanding potency of ablative radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 70, 847852 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.10.059
150.
150.B. D. Kavanagh and F. Newman, “Toward a unified survival curve: In regard to Park et al. [Int. J. Radiat. Oncol., Biol., Phys. 70, 847–852 (2008) and Krueger et al., Int. J. Radiat. Oncol., Biol., Phys. 69, 1262–1271 (2007)],” Int. J. Radiat. Oncol., Biol., Phys. 71, 958959 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2008.03.016
151.
151.N. E. Dunlap, J. Cai, G. B. Biedermann, W. Yang, S. H. Benedict, K. Sheng, T. E. Schefter, B. D. Kavanagh and J. M. Larner, “Chest wall volume receiving predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 76, 796801 (2009).
152.
152.R. Timmerman, R. McGarry, C. Yiannoutsos, L. Papiez, K. Tudor, J. DeLuca, M. Ewing, R. Abdulrahman, C. DesRosiers, M. Williams, and J. Fletcher, “Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer,” J. Clin. Oncol. 24, 48334839 (2006).
http://dx.doi.org/10.1200/JCO.2006.07.5937
153.
153.R. D. Timmerman, B. D. Kavanagh, L. C. Cho, L. Papiez, and L. Xing, “Stereotactic body radiation therapy in multiple organ sites,” J. Clin. Oncol. 25, 947952 (2007).
http://dx.doi.org/10.1200/JCO.2006.09.7469
154.
154.J. D. Murphy, S. Dieterich, D. T. Chang, and A. C. Koong, “duodenal toxicity in single-fraction stereotactic body radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 75, S29S30 (2009).
http://dx.doi.org/10.1016/j.ijrobp.2009.07.090
155.
155.L. J. Hazard, B. Wang, T. B. Skidmore, S. S. Chern, B. J. Salter, R. L. Jensen, and D. C. Shrieve, “Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator,” Int. J. Radiat. Oncol., Biol., Phys. 73, 562570 (2009).
http://dx.doi.org/10.1016/j.ijrobp.2008.04.026
156.
156.F. F. Yin, S. Ryu, M. Ajlouni, J. Zhu, H. Yan, H. Guan, K. Faber, J. Rock, M. Abdalhak, L. Rogers, M. Rosenblum, and J. H. Kim, “A technique of intensity-modulated radiosurgery (IMRS) for spinal tumors,” Med. Phys. 29, 28152822 (2002).
http://dx.doi.org/10.1118/1.1521722
157.
157.M. Guckenberger, J. Meyer, J. Wilbert, K. Baier, O. Sauer, and M. Flentje, “Precision of image-guided radiotherapy (IGRT) in six degrees of freedom and limitations in clinical practice,” Strahlenther. Onkol. 183, 307313 (2007).
http://dx.doi.org/10.1007/s00066-007-1695-0
158.
158.G. Soete, D. Verellen, K. Tournel, and G. Storme, “Setup accuracy of stereoscopic x-ray positioning with automated correction for rotational errors in patients treated with conformal arc radiotherapy for prostate cancer,” Radiother. Oncol. 80, 371373 (2006).
http://dx.doi.org/10.1016/j.radonc.2006.07.001
159.
159.S. I. Ryu, S. D. Chang, D. H. Kim, M. J. Murphy, Q. T. Le, D. P. Martin, and J. R. Adler, Jr., “Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions,” Neurosurgery 49, 838846 (2001).
http://dx.doi.org/10.1097/00006123-200110000-00011
160.
160.M. Fuss, B. J. Salter, P. Rassiah, D. Cheek, S. X. Cavanaugh, and T. S. Herman, “Repositioning accuracy of a commercially available double-vacuum whole body immobilization system for stereotactic body radiation therapy,” Technol. Cancer Res. Treat. 3, 5967 (2004).
161.
161.L. Wang, R. Jacob, L. Chen, C. Ma, B. Movsas, S. Feigenberg, and A. Konski, “Stereotactic IMRT for prostate cancer: Setup accuracy of a new stereotactic body localization system,” J. Appl. Clin. Med. Phys. 5, 1828 (2004).
http://dx.doi.org/10.1120/jacmp.2020.21705
162.
162.D. M. Lovelock, C. Hua, P. Wang, M. Hunt, N. Fournier-Bidoz, K. Yenice, S. Toner, W. Lutz, H. Amols, M. Bilsky, Z. Fuks, and Y. Yamada, “Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging,” Med. Phys. 32, 26062614 (2005).
http://dx.doi.org/10.1118/1.1951042
163.
163.A. S. Shiu, E. L. Chang, J. S. Ye, M. Lii, L. D. Rhines, E. Mendel, J. Weinberg, S. Singh, M. H. Maor, R. Mohan, and J. D. Cox, “Near simultaneous computed tomography image-guided stereotactic spinal radiotherapy: An emerging paradigm for achieving true stereotaxy,” Int. J. Radiat. Oncol., Biol., Phys. 57, 605613 (2003).
http://dx.doi.org/10.1016/S0360-3016(03)00792-2
164.
164.J. Pouliot, A. Bani-Hashemi, J. Chen, M. Svatos, F. Ghelmansarai, M. Mitschke, M. Aubin, P. Xia, O. Morin, K. Bucci, M. Roach III, P. Hernandez, Z. Zheng, D. Hristov, and L. Verhey, “Low-dose megavoltage cone-beam CT for radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 61, 552560 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2004.10.011
165.
165.D. A. Jaffray, “Emergent technologies for 3-dimensional image-guided radiation delivery,” Semin. Radiat. Oncol. 15, 208216 (2005).
http://dx.doi.org/10.1016/j.semradonc.2005.01.003
166.
166.D. A. Jaffray, “Kilovoltage volumetric imaging in the treatment room,” Front. Radiat. Ther. Oncol. 40, 116131 (2007).
http://dx.doi.org/10.1159/000106031
167.
167.D. A. Jaffray, J. H. Siewerdsen, J. W. Wong, and A. A. Martinez, “Flat-panel cone-beam computed tomography for image-guided radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 53, 13371349 (2002).
http://dx.doi.org/10.1016/S0360-3016(02)02884-5
168.
168.T. R. Mackie et al., “Image guidance for precise conformal radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 56, 89105 (2003).
http://dx.doi.org/10.1016/S0360-3016(03)00090-7
169.
169.S. D. Chang, W. Main, D. P. Martin, I. C. Gibbs, and M. P. Heilbrun, “An analysis of the accuracy of the CyberKnife: A robotic frameless stereotactic radiosurgical system,” Neurosurgery 52, 140147 (2003).
http://dx.doi.org/10.1097/00006123-200301000-00018
170.
170.D. Verellen, G. Soete, N. Linthout, S. Van Acker, P. De Roover, V. Vinh-Hung, J. Van de Steene, and G. Storme, “Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging,” Radiother. Oncol. 67, 129141 (2003).
http://dx.doi.org/10.1016/S0167-8140(02)00385-7
171.
171.H. Shirato, S. Shimizu, T. Kunieda, K. Kitamura, M. van Herk, K. Kagei, T. Nishioka, S. Hashimoto, K. Fujita, H. Aoyama, K. Tsuchiya, K. Kudo, and K. Miyasaka, “Physical aspects of a real-time tumor-tracking system for gated radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 48, 11871195 (2000).
http://dx.doi.org/10.1016/S0360-3016(00)00748-3
172.
172.J. M. Balter, H. M. Sandler, K. Lam, R. L. Bree, A. S. Lichter, and R. K. ten Haken, “Measurement of prostate movement over the course of routine radiotherapy using implanted markers,” Int. J. Radiat. Oncol., Biol., Phys. 31, 113118 (1995).
http://dx.doi.org/10.1016/0360-3016(94)00382-U
173.
173.P. W. Chung, T. Haycocks, T. Brown, Z. Cambridge, V. Kelly, H. Alasti, D. A. Jaffray, and C. N. Catton, “On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma,” Int. J. Radiat. Oncol., Biol., Phys. 60, 329334 (2004).
http://dx.doi.org/10.1016/j.ijrobp.2004.07.150
174.
174.E. Vigneault, J. Pouliot, J. Laverdiere, J. Roy, and M. Dorion, “Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: A clinical study,” Int. J. Radiat. Oncol., Biol., Phys. 37, 205212 (1997).
http://dx.doi.org/10.1016/S0360-3016(96)00341-0
175.
175.R. E. Wurm, F. Gum, S. Erbel, L. Schlenger, D. Scheffler, D. Agaoglu, R. Schild, B. Gebauer, P. Rogalla, M. Plotkin, K. Ocran, and V. Budach, “Image guided respiratory gated hypofractionated stereotactic body radiation therapy (H-SBRT) for liver and lung tumors: Initial experience,” Acta Oncol. 45, 881889 (2006).
http://dx.doi.org/10.1080/02841860600919233
176.
176.J. de Mey, J. Van de Steene, F. Vandenbroucke, D. Verellen, L. Trappeniers, M. Meysman, H. Everaert, M. Noppen, G. Storme, and A. Bossuyt, “Percutaneous placement of marking coils before stereotactic radiation therapy of malignant lung lesions,” J. Vasc. Interv. Radiol. 16, 5156 (2005).
177.
177.M. Imura, K. Yamazaki, H. Shirato, R. Onimaru, M. Fujino, S. Shimizu, T. Harada, S. Ogura, H. Dosaka-Akita, K. Miyasaka, and M. Nishimura, “Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 63, 14421447 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2005.04.024
178.
178.H. Shirato, K. Suzuki, G. C. Sharp, K. Fujita, R. Onimaru, M. Fujino, N. Kato, Y. Osaka, R. Kinoshita, H. Taguchi, S. Onodera, and K. Miyasaka, “Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 64, 12291236 (2006).
http://dx.doi.org/10.1016/j.ijrobp.2005.11.016
179.
179.T. R. Willoughby, A. R. Forbes, D. Buchholz, K. M. Langen, T. H. Wagner, O. A. Zeidan, P. A. Kupelian, and S. L. Meeks, “Evaluation of an infrared camera and x-ray system using implanted fiducials in patients with lung tumors for gated radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 66, 568575 (2006).
http://dx.doi.org/10.1016/j.ijrobp.2006.05.029
180.
180.P. M. Medin, T. D. Solberg, A. A. De Salles, C. H. Cagnon, M. T. Selch, J. P. Johnson, J. B. Smathers, and E. R. Cosman, “Investigations of a minimally invasive method for treatment of spinal malignancies with LINAC stereotactic radiation therapy: Accuracy and animal studies,” Int. J. Radiat. Oncol., Biol., Phys. 52, 11111122 (2002).
http://dx.doi.org/10.1016/S0360-3016(01)02762-6
181.
181.M. J. Murphy, S. Chang, I. Gibbs, Q. T. Le, D. Martin, and D. Kim, “Image-guided radiosurgery in the treatment of spinal metastases,” Neurosurg. Focus 11 (2001).
http://dx.doi.org/10.3171/foc.2001.11.6.7
182.
182.T. Naruke, T. Goya, R. Tsuchiya, and K. Suemasu, “Prognosis and survival in resected lung carcinoma based on the new international staging system,” J. Thorac. Cardiovasc. Surg. 96, 440447 (1988).
183.
183.M. Uematsu, A. Shioda, A. Suda, T. Fukui, Y. Ozeki, Y. Hama, J. R. Wong, and S. Kusano, “Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: A 5-year experience,” Int. J. Radiat. Oncol., Biol., Phys. 51, 666670 (2001).
http://dx.doi.org/10.1016/S0360-3016(01)01703-5
184.
184.S. L. Meeks, J. M. Buatti, L. G. Bouchet, F. J. Bova, T. C. Ryken, E. C. Pennington, K. M. Anderson, and W. A. Friedman, “Ultrasound-guided extracranial radiosurgery: Technique and application,” Int. J. Radiat. Oncol., Biol., Phys. 55, 10921101 (2003).
http://dx.doi.org/10.1016/S0360-3016(02)04406-1
185.
185.M. Fuss, J. Boda-Heggemann, N. Papanikolau, and B. J. Salter, “Image-guidance for stereotactic body radiation therapy,” Med. Dosim. 32, 102110 (2007).
http://dx.doi.org/10.1016/j.meddos.2007.01.007
186.
186.D. A. Kuban, L. Dong, R. Cheung, E. Strom, and R. De Crevoisier, “Ultrasound-based localization,” Semin. Radiat. Oncol. 15, 180191 (2005).
http://dx.doi.org/10.1016/j.semradonc.2005.01.009
187.
187.J. M. Balter, J. N. Wright, L. J. Newell, B. Friemel, S. Dimmer, Y. Cheng, J. Wong, E. Vertatschitsch, and T. P. Mate, “Accuracy of a wireless localization system for radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 61, 933937 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2004.11.009
188.
188.P. J. Keall, G. S. Mageras, J. M. Balter, R. S. Emery, K. M. Forster, S. B. Jiang, J. M. Kapatoes, D. A. Low, M. J. Murphy, B. R. Murray, C. R. Ramsey, M. B. Van Herk, S. S. Vedam, J. W. Wong, and E. Yorke, “The management of respiratory motion in radiation oncology report of AAPM Task Group 76,” Med. Phys. 33, 38743900 (2006).
http://dx.doi.org/10.1118/1.2349696
189.
189.T. Zhang, N. P. Orton, and W. A. Tome, “On the automated definition of mobile target volumes from 4D-CT images for stereotactic body radiotherapy,” Med. Phys. 32, 34933502 (2005).
http://dx.doi.org/10.1118/1.2106448
190.
190.J. W. Wolthaus, C. Schneider, J. J. Sonke, M. van Herk, J. S. Belderbos, M. M. Rossi, J. V. Lebesque, and E. M. Damen, “Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients,” Int. J. Radiat. Oncol., Biol., Phys. 65, 15601571 (2006).
http://dx.doi.org/10.1016/j.ijrobp.2006.04.031
191.
191.F. Casamassima, C. Cavedon, P. Francescon, J. Stancanello, M. Avanzo, S. Cora, and P. Scalchi, “Use of motion tracking in stereotactic body radiotherapy: Evaluation of uncertainty in off-target dose distribution and optimization strategies,” Acta Oncol. 45, 943947 (2006).
http://dx.doi.org/10.1080/02841860600908962
192.
192.G. R. Borst, J. J. Sonke, A. Betgen, P. Remeijer, M. van Herk, and J. V. Lebesque, “Kilo-voltage cone-beam computed tomography setup measurements for lung cancer patients; first clinical results and comparison with electronic portal-imaging device,” Int. J. Radiat. Oncol., Biol., Phys. 68, 555561 (2007).
http://dx.doi.org/10.1016/j.ijrobp.2007.01.014
193.
193.T. G. Purdie, J. P. Bissonnette, K. Franks, A. Bezjak, D. Payne, F. Sie, M. B. Sharpe, and D. A. Jaffray, “Cone-beam computed tomography for on-line image guidance of lung stereotactic radiotherapy: Localization, verification, and intrafraction tumor position,” Int. J. Radiat. Oncol., Biol., Phys. 68, 243252 (2007).
http://dx.doi.org/10.1016/j.ijrobp.2006.12.022
194.
194.M. Guckenberger, J. Meyer, J. Wilbert, K. Baier, G. Mueller, J. Wulf, and M. Flentje, “Cone-beam CT based image-guidance for extracranial stereotactic radiotherapy of intrapulmonary tumors,” Acta Oncol. 45, 897906 (2006).
http://dx.doi.org/10.1080/02841860600904839
195.
195.G. D. Hugo, J. Liang, J. Campbell, and D. Yan, “On-line target position localization in the presence of respiration: A comparison of two methods,” Int. J. Radiat. Oncol., Biol., Phys. 69, 16341641 (2007).
http://dx.doi.org/10.1016/j.ijrobp.2007.08.023
196.
196.Z. Wang, Q. J. Wu, L. B. Marks, N. Larrier, and F. F. Yin, “Cone-beam CT localization of internal target volumes for stereotactic body radiotherapy of lung lesions,” Int. J. Radiat. Oncol., Biol., Phys. 69, 16181624 (2007).
http://dx.doi.org/10.1016/j.ijrobp.2007.08.030
197.
197.J. J. Sonke, L. Zijp, P. Remeijer, and M. van Herk, “Respiratory correlated cone beam CT,” Med. Phys. 32, 11761186 (2005).
http://dx.doi.org/10.1118/1.1869074
198.
198.S. L. Meeks, W. A. Tome, T. R. Willoughby, P. A. Kupelian, T. H. Wagner, J. M. Buatti, and F. J. Bova, “Optically guided patient positioning techniques,” Semin. Radiat. Oncol. 15, 192201 (2005).
http://dx.doi.org/10.1016/j.semradonc.2005.01.004
199.
199.G. Baroni, G. Ferrigno, and A. Pedotti, “Implementation and application of real-time motion analysis based on passive markers,” Med. Biol. Eng. Comput. 36, 693703 (1998).
http://dx.doi.org/10.1007/BF02518871
200.
200.F. J. Bova, J. M. Buatti, W. A. Friedman, W. M. Mendenhall, C. C. Yang, and C. Liu, “The University of Florida frameless high-precision stereotactic radiotherapy system,” Int. J. Radiat. Oncol., Biol., Phys. 38, 875882 (1997).
http://dx.doi.org/10.1016/S0360-3016(97)00055-2
201.
201.H. D. Kubo, P. M. Len, S. Minohara, and H. Mostafavi, “Breathing-synchronized radiotherapy program at the University of California Davis Cancer Center,” Med. Phys. 27, 346353 (2000).
http://dx.doi.org/10.1118/1.598837
202.
202.M. Menke, F. Hirschfeld, T. Mack, O. Pastyr, V. Sturm, and W. Schlegel, “Photogrammetric accuracy measurements of head holder systems used for fractionated radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 29, 11471155 (1994).
http://dx.doi.org/10.1016/0360-3016(94)90412-X
203.
203.R. D. Rogus, R. L. Stern, and H. D. Kubo, “Accuracy of a photogrammetry-based patient positioning and monitoring system for radiation therapy,” Med. Phys. 26, 721728 (1999).
http://dx.doi.org/10.1118/1.598578
204.
204.L. T. Wang, T. D. Solberg, P. M. Medin, and R. Boone, “Infrared patient positioning for stereotactic radiosurgery of extracranial tumors,” Comput. Biol. Med. 31, 101111 (2001).
http://dx.doi.org/10.1016/S0010-4825(00)00026-3
205.
205.C. Bert, K. G. Metheany, K. Doppke, and G. T. Chen, “A phantom evaluation of a stereo-vision surface imaging system for radiotherapy patient setup,” Med. Phys. 32, 27532762 (2005).
http://dx.doi.org/10.1118/1.1984263
206.
206.A. Muacevic, C. Drexler, B. Wowra, A. Schweikard, A. Schlaefer, R. T. Hoffmann, R. Wilkowski, H. Winter, and M. Reiser, “Technical description, phantom accuracy, and clinical feasibility for single-session lung radiosurgery using robotic image-guided real-time respiratory tumor tracking,” Technol. Cancer Res. Treat. 6, 321328 (2007).
207.
207.A. Schweikard, G. Glosser, M. Bodduluri, M. J. Murphy, and J. R. Adler, “Robotic motion compensation for respiratory movement during radiosurgery,” Comput. Aided Surg. 5, 263277 (2000).
http://dx.doi.org/10.3109/10929080009148894
208.
208.A. Schweikard, H. Shiomi, and J. Adler, “Respiration tracking in radiosurgery,” Med. Phys. 31, 27382741 (2004).
http://dx.doi.org/10.1118/1.1774132
209.
209.D. Ionascu, S. B. Jiang, S. Nishioka, H. Shirato, and R. I. Berbeco, “Internal-external correlation investigations of respiratory induced motion of lung tumors,” Med. Phys. 34, 38933903 (2007).
http://dx.doi.org/10.1118/1.2779941
210.
210.M. Guckenberger, T. Krieger, A. Richter, K. Baier, J. Wilbert, R. A. Sweeney, and M. Flentje, “Potential of image-guidance, gating and real-time tracking to improve accuracy in pulmonary stereotactic body radiotherapy,” Radiother. Oncol. 91, 288295 (2009).
http://dx.doi.org/10.1016/j.radonc.2008.08.010
211.
211.H. D. Kubo and B. C. Hill, “Respiration gated radiotherapy treatment: A technical study,” Phys. Med. Biol. 41, 8391 (1996).
http://dx.doi.org/10.1088/0031-9155/41/1/007
212.
212.R. W. Underberg, F. J. Lagerwaard, B. J. Slotman, J. P. Cuijpers, and S. Senan, “Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: An analysis of 4DCT datasets,” Int. J. Radiat. Oncol., Biol., Phys. 62, 554560 (2005).
http://dx.doi.org/10.1016/j.ijrobp.2005.01.032
213.
213.E. C. Ford, G. S. Mageras, E. Yorke, K. E. Rosenzweig, R. Wagman, and C. C. Ling, “Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging,” Int. J. Radiat. Oncol., Biol., Phys. 52, 522531 (2002).
http://dx.doi.org/10.1016/S0360-3016(01)02681-5
214.
214.H. D. Kubo and L. Wang, “Introduction of audio gating to further reduce organ motion in breathing synchronized radiotherapy,” Med. Phys. 29, 345350 (2002).
http://dx.doi.org/10.1118/1.1448826
215.
215.G. S. Mageras, E. Yorke, K. Rosenzweig, L. Braban, E. Keatley, E. Ford, S. A. Leibel, and C. C. Ling, “Fluoroscopic evaluation of diaphragmatic motion reduction with a respiratory gated radiotherapy system,” J. Appl. Clin. Med. Phys. 2, 191200 (2001).
http://dx.doi.org/10.1120/1.1409235
216.
216.S. S. Korreman, T. Juhler-Nottrup, and A. L. Boyer, “Respiratory gated beam delivery cannot facilitate margin reduction, unless combined with respiratory correlated image guidance,” Radiother. Oncol. 86, 6168 (2008).
http://dx.doi.org/10.1016/j.radonc.2007.10.038
217.
217.B. E. Bjärngard, J. S. Tsai, and R. K. Rice, “Doses on the central axes of narrow 6-MV x-ray beams,” Med. Phys. 17, 794799 (1990).
http://dx.doi.org/10.1118/1.596475
218.
218.J. Y. Cheung, K. N. Yu, R. T. Ho, and C. P. Yu, “Monte Carlo calculated output factors of a Leksell Gamma Knife unit,” Phys. Med. Biol. 44, N247N249 (1999).
http://dx.doi.org/10.1088/0031-9155/44/12/401
219.
219.W. U. Laub and T. Wong, “The volume effect of detectors in the dosimetry of small fields used in IMRT,” Med. Phys. 30, 341347 (2003).
http://dx.doi.org/10.1118/1.1544678
220.
220.Y. Yang and L. Xing, “Using the volumetric effect of a finite-sized detector for routine quality assurance of multileaf collimator leaf positioning,” Med. Phys. 30, 433441 (2003).
http://dx.doi.org/10.1118/1.1543150
221.
221.C. Martens, C. De Wagter, and W. De Neve, “The value of the PinPoint ion chamber for characterization of small field segments used in intensity-modulated radiotherapy,” Phys. Med. Biol. 45, 25192530 (2000).
http://dx.doi.org/10.1088/0031-9155/45/9/306
222.
222.K. A. Paskalev, J. P. Seuntjens, H. J. Patrocinio, and E. B. Podgorsak, “Physical aspects of dynamic stereotactic radiosurgery with very small photon beams (1.5 and 3 mm in diameter),” Med. Phys. 30, 111118 (2003).
http://dx.doi.org/10.1118/1.1536290
223.
223.S. C. Prasad, “Effects of collimator jaw setting on dose output for treatments with multileaf collimator,” Med. Dosim. 23, 296298 (1998).
http://dx.doi.org/10.1016/S0958-3947(98)00031-4
224.
224.S. Webb, T. Bortfeld, J. Stein, and D. Convery, “The effect of stair-step leaf transmission on the ‘tongue-and-groove problem’ in dynamic radiotherapy with a multileaf collimator,” Phys. Med. Biol. 42, 595602 (1997).
http://dx.doi.org/10.1088/0031-9155/42/3/011
225.
225.A. Mack, S. G. Scheib, J. Major, S. Gianolini, G. Pazmandi, H. Feist, H. Czempiel, and H. J. Kreiner, “Precision dosimetry for narrow photon beams used in radiosurgery-determination of Gamma Knife output factors,” Med. Phys. 29, 20802089 (2002).
http://dx.doi.org/10.1118/1.1501138
226.
226.K. De Vlamynck, H. Palmans, F. Verhaegen, C. De Wagter, W. De Neve, and H. Thierens, “Dose measurements compared with Monte Carlo simulations of narrow 6 MV multileaf collimator shaped photon beams,” Med. Phys. 26, 18741882 (1999).
http://dx.doi.org/10.1118/1.598693
227.
227.T. C. Zhu and B. E. Bjarngard, “The head-scatter factor for small field sizes,” Med. Phys. 21, 6568 (1994).
http://dx.doi.org/10.1118/1.597256
228.
228.X. R. Zhu, J. J. Allen, J. Shi, and W. E. Simon, “Total scatter factors and tissue maximum ratios for small radiosurgery fields: Comparison of diode detectors, a parallel-plate ion chamber, and radiographic film,” Med. Phys. 27, 472477 (2000).
http://dx.doi.org/10.1118/1.598915
229.
229.S. Li, A. Rashid, S. He, and D. Djajaputra, “A new approach in dose measurement and error analysis for narrow photon beams (beamlets) shaped by different multileaf collimators using a small detector,” Med. Phys. 31, 20202032 (2004).
http://dx.doi.org/10.1118/1.1760191
230.
230.P. D. Higgins, C. H. Sibata, L. Siskind, and J. W. Sohn, “Deconvolution of detector size effect for small field measurement,” Med. Phys. 22, 16631666 (1995).
http://dx.doi.org/10.1118/1.597427
231.
231.E. R. Epp, A. L. Boyer, and K. P. Doppke, “Underdosing of lesions resulting from lack of electronic equilibrium in upper respiratory air cavities irradiated by 10MV x-ray beams,” Int. J. Radiat. Oncol., Biol., Phys. 2, 613619 (1977).
http://dx.doi.org/10.1016/0360-3016(77)90040-2
232.
232.C. Martens, N. Reynaert, C. De Wagter, P. Nilsson, M. Coghe, H. Palmans, H. Thierens, and W. De Neve, “Underdosage of the upper-airway mucosa for small fields as used in intensity-modulated radiation therapy: A comparison between radiochromic film measurements, Monte Carlo simulations, and collapsed cone convolution calculations,” Med. Phys. 29, 15281535 (2002).
http://dx.doi.org/10.1118/1.1487421
233.
233.A. K. Rustgi, A. Samuels, and S. N. Rustgi, “Influence of air inhomogeneities in radiosurgical beams,” Med. Dosim. 22, 95100 (1997).
http://dx.doi.org/10.1016/S0958-3947(97)00001-0
234.
234.M. K. Woo and J. R. Cunningham, “The validity of the density scaling method in primary electron transport for photon and electron beams,” Med. Phys. 17, 187194 (1990).
http://dx.doi.org/10.1118/1.596497
235.
235.E. K. Lee, T. Fox, and I. Crocker, “Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 64, 301320 (2006).
http://dx.doi.org/10.1016/j.ijrobp.2005.08.023
236.
236.N. Papanikolaou, J. Battista, A. Boyer, C. Kappas, E. Klein, T. Mackie, M. Sharpe, and J. Van Dyke, AAPM Report No. 85: Tissue Inhomogeneity Corrections for Megavoltage Photon Beams, American Association of Physicists in Medicine (2004).
237.
237.S. E. Davidson, R. A. Popple, G. S. Ibbott, and D. S. Followill, “Technical note: Heterogeneity dose calculation accuracy in IMRT: Study of five commercial treatment planning systems using an anthropomorphic thorax phantom,” Med. Phys. 35, 54345439 (2008).
http://dx.doi.org/10.1118/1.3006353
238.
238.L. Potters, M. Steinberg, C. Rose, R. Timmerman, S. Ryu, J. M. Hevezi, J. Welsh, M. Mehta, D. A. Larson, and N. A. Janjan, “American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 60, 10261032 (2004).
http://dx.doi.org/10.1016/j.ijrobp.2004.06.114
239.
239.M. D. Mills, “Analysis and practical use: The ABT study of medical physicist work values for radiation oncology physics services—Round II,” J. Am. Coll. Radiol. 2, 782789 (2005).
http://dx.doi.org/10.1016/j.jacr.2005.02.009
240.
240.I. ABT Associates, 2008.
241.
241.J. R. Palta, C. Liu, and J. G. Li, “Quality assurance of intensity-modulated radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 71, S108S112 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.05.092
242.
242.E. E. Klein, J. Hanley, J. Bayouth, F. -F. Yin, W. Simon, S. Dresser, C. Serago, F. Aguirre, L. Ma, B. Arjomandy, and C. Liu, “AAPM Task Group 142 report: Quality assurance of medical accelerators,” Med. Phys. 36, 41974212 (2009)
243.
243.G. J. Kutcher et al., “Comprehensive QA for radiation oncology: Report of AAPM Radiation Therapy Committee Task Group 40,” Med. Phys. 21, 581618 (1994).
http://dx.doi.org/10.1118/1.597316
244.
244.R. Nath, P. J. Biggs, F. J. Bova, C. C. Ling, J. A. Purdy, J. van de Geijn, and M. S. Weinhous, “AAPM code of practice for radiotherapy accelerators: Report of AAPM Radiation Therapy Task Group No. 45,” Med. Phys. 21, 10931121 (1994).
http://dx.doi.org/10.1118/1.597398
245.
245.P. Lin et al., “Specification and acceptance testing for computed tomography scanners,” AAPM Report No. 39, Vol. 95 (American Institute of Physics, Inc., 1993).
246.
246.J. G. Och, G. D. Clarke, W. T. Sobol, C. W. Rosen, and S. K. Mun, “Acceptance testing of magnetic resonance imaging systems: Report of AAPM Nuclear Magnetic Resonance Task Group No. 6,” Med. Phys. 19, 217229 (1992).
http://dx.doi.org/10.1118/1.596903
247.
247.B. Fraass, K. Doppke, M. Hunt, G. Kutcher, G. Starkschall, R. Stern, and J. Van Dyke, “American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning,” Med. Phys. 25, 17731829 (1998).
http://dx.doi.org/10.1118/1.598373
248.
248.G. A. Ezzell, J. M. Galvin, D. Low, J. R. Palta, I. Rosen, M. B. Sharpe, P. Xia, Y. Xiao, L. Xing, and C. X. Yu, “Guidance document on delivery, treatment planning, and clinical implementation of IMRT: Report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee,” Med. Phys. 30, 20892115 (2003).
http://dx.doi.org/10.1118/1.1591194
249.
249.Quality assurance for radiation therapy, quality assurance of radiation therapy: The challenges of advanced technologies symposium,” Int. J. Radiat. Oncol., Biol., Phys. 71, S1S214 (2008).
250.
250.W. Lutz, K. R. Winston, and N. Maleki, “A system for stereotactic radiosurgery with a linear accelerator,” Int. J. Radiat. Oncol., Biol., Phys. 14, 373381 (1988).
http://dx.doi.org/10.1016/0360-3016(88)90446-4
251.
251.J. P. Bissonnette, “Quality assurance of image-guidance technologies,” Semin. Radiat. Oncol. 17, 278286 (2007).
http://dx.doi.org/10.1016/j.semradonc.2007.07.002
252.
252.F. Lohr, J. Debus, C. Frank, K. Herfarth, O. Pastyr, B. Rhein, M. L. Bahner, W. Schlegel, and M. Wannenmacher, “Noninvasive patient fixation for extracranial stereotactic radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 45, 521527 (1999).
http://dx.doi.org/10.1016/S0360-3016(99)00190-X
253.
253.C. Yu, W. Main, D. Taylor, G. Kuduvalli, M. L. Apuzzo, and J. R. Adler, Jr., “An anthropomorphic phantom study of the accuracy of Cyberknife spinal radiosurgery,” Neurosurgery 55, 11381149 (2004).
http://dx.doi.org/10.1227/01.NEU.0000141080.54647.11
254.
254.F. Rath, “Tools for developing a quality management program: Proactive tools (process mapping, value stream mapping, fault tree analysis, and failure mode and effects analysis),” Int. J. Radiat. Oncol., Biol., Phys. 71, S187S190 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.07.2385
255.
255.J. Nyman, K. A. Johansson, and U. Hulten, “Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patients,” Lung Cancer 51, 97103 (2006).
http://dx.doi.org/10.1016/j.lungcan.2005.08.011
256.
256.W. Hodge, W. A. Tome, H. A. Jaradat, N. P. Orton, D. Khuntia, A. Traynor, T. Weigel, and M. P. Mehta, “Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation,” Acta Oncol. 45, 890896 (2006).
http://dx.doi.org/10.1080/02841860600907329
257.
257.A. J. Hamilton, B. A. Lulu, H. Fosmire, B. Stea, and J. R. Cassady, “Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery,” Neurosurgery 36, 311319 (1995).
http://dx.doi.org/10.1227/00006123-199502000-00010
258.
258.M. J. Murphy, “An automatic six-degree-of-freedom image registration algorithm for image-guided frameless stereotaxic radiosurgery,” Med. Phys. 24, 857866 (1997).
http://dx.doi.org/10.1118/1.598005
259.
259.K. Nakagawa, Y. Aoki, M. Tago, A. Terahara, and K. Ohtomo, “Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: Original research in the treatment of thoracic neoplasms,” Int. J. Radiat. Oncol., Biol., Phys. 48, 449457 (2000).
http://dx.doi.org/10.1016/S0360-3016(00)00617-9
260.
260.J. Wulf, U. Hadinger, U. Oppitz, B. Olshausen, and M. Flentje, “Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame,” Radiother. Oncol. 57, 225236 (2000).
http://dx.doi.org/10.1016/S0167-8140(00)00226-7
261.
261.M. B. Sharpe, D. J. Moseley, T. G. Purdie, M. Islam, J. H. Siewerdsen, and D. A. Jaffray, “The stability of mechanical calibration for a kV cone beam computed tomography system integrated with linear accelerator,” Med. Phys. 33, 136144 (2006).
http://dx.doi.org/10.1118/1.2143141
262.
262.J. M. Galvin and G. Bednarz, “Quality assurance procedures for stereotactic body radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 71, S122S125 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.10.002
263.
263.T. D. Solberg, P. M. Medin, J. Mullins, and S. Li, “Quality assurance of immobilization and target localization systems for frameless stereotactic cranial and extracranial hypofractionated radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 71, S131S135 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.05.097
264.
264.S. B. Jiang, J. Wolfgang, and G. S. Mageras, “Quality assurance challenges for motion-adaptive radiation therapy: Gating, breath holding, and four-dimensional computed tomography,” Int. J. Radiat. Oncol., Biol., Phys. 71, S103S107 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.07.2386
265.
265.J. P. Bissonnette, D. Moseley, E. White, M. Sharpe, T. Purdie, and D. A. Jaffray, “Quality assurance for the geometric accuracy of cone-beam CT guidance in radiation therapy,” Int. J. Radiat. Oncol., Biol., Phys. 71, S57S61 (2008).
http://dx.doi.org/10.1016/j.ijrobp.2007.06.086
266.
266.R. Timmerman, personal communication (26 October 2009).
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/37/8/10.1118/1.3438081
Loading
/content/aapm/journal/medphys/37/8/10.1118/1.3438081
Loading

Data & Media loading...

Loading

Article metrics loading...

/content/aapm/journal/medphys/37/8/10.1118/1.3438081
2010-07-14
2015-07-29

Abstract

Task Group 101 of the AAPM has prepared this report for medical physicists, clinicians, and therapists in order to outline the best practice guidelines for the external-beam radiation therapy technique referred to as stereotactic body radiation therapy (SBRT). The task group report includes a review of the literature to identify reported clinical findings and expected outcomes for this treatment modality. Information is provided for establishing a SBRT program, including protocols, equipment, resources, and QA procedures. Additionally, suggestions for developing consistent documentation for prescribing, reporting, and recording SBRT treatment delivery is provided.

Loading

Full text loading...

/deliver/fulltext/aapm/journal/medphys/37/8/1.3438081.html;jsessionid=b6r4h9bah6pmf.x-aip-live-06?itemId=/content/aapm/journal/medphys/37/8/10.1118/1.3438081&mimeType=html&fmt=ahah&containerItemId=content/aapm/journal/medphys
true
true
This is a required field
Please enter a valid email address

Oops! This section does not exist...

Use the links on this page to find existing content.

752b84549af89a08dbdd7fdb8b9568b5 journal.articlezxybnytfddd
Scitation: Stereotactic body radiation therapy: The report of AAPM Task Group 101
http://aip.metastore.ingenta.com/content/aapm/journal/medphys/37/8/10.1118/1.3438081
10.1118/1.3438081
SEARCH_EXPAND_ITEM